Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)

PHASE2CompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

January 23, 2024

Study Completion Date

February 15, 2024

Conditions
Atopic DermatitisSkin Diseases
Interventions
DRUG

Orismilast modified release tablets

"Orismilast modified release is a next generation PDE4 inhibitor with high selectivity for the PD4 subtypes linked to inflammation.~Other Names:~* UNI50001~* LEO32731"

DRUG

Placebo

Placebo matching tablets

Trial Locations (48)

1097

Hautarztpraxis Dr.Gerlach, Dresden

10022

Juva Skin & Laser Center, New York

10075

Sadick Research Group LLC, New York

24148

MVZ DermaKiel GmbH, Kiel

33135

Advance Medical Research Center, Miami

33607

Clinical Research Trials of Florida ,Inc., Tampa

33615

Alliance Clinical Research of Tampa, Tampa

44124

Apex Clinical Research Center, Mayfield Heights

48084

Revival Research Institute, LLC, Troy

48328

Michigan Dermatology Institute, Waterford

77074

Clinical Trial Network, Houston

77598

Tranquility Research, Webster

89109

Excel Clinical Research, Las Vegas

90057

LA Universal Research Center, INC., Los Angeles

90301

Axon Clinical Research, Inglewood

91303

Hope Clinical Research, Canoga Park

92120

Acclaim Clinical Research Inc., San Diego

92708

First OC Dermatology Research Inc, Fountain Valley

01915

ALLCUTIS Research, LLC, Beverly

03801

ALLCUTIS Research, LLC, Portsmouth

Unknown

Fachklinik Bad Bentheim, Bad Bentheim

ISA - Interdisciplinary Study Association GmbH, Berlin

Rosenpark Research GmbH, Darmstadt

TFS Trial From Support GmbH, Hamburg

Studienzentrum Dr.Beate Schwarz, Langenau

Ludwig-Maximilians-Universitaet Muenchen - Klinik und Poliklinik fuer Dermatologie und Allergologie, Munich

KliFOs - Klinische Forschung Osnabrueck, Osnabrück

Obudai Egeszsegugyi Centrum, Budapest

Dermamed Research Kft, Orosháza

PTE AOK, Pécs

Obudai Egeszsegugyi Centrum, Zalaegerszeg

NZOZ Specjalistyczny Orodek Dermatologiczny DERMAL, Bialystok

Specjalistyczna Praktyka Lekarska Gabinet Dermatologiczny dr n.med. Edyta Gebska, Chorzów

Zespol Naukowo - Leczniczy Dermatologiczne Centrum Uzdrowiskowe Iwolang Sp. z o.o., Iwonicz-Zdrój

Provita Sp. z o.o., Katowice

Centrum Medyczne All-Med, Krakow

Klinika Badawcza, Malbork

Laser Clinic, Szczecin

Klinika Ambroziak, Warsaw

CityClinic Przychodnia Lekarsko-Psychologiczna, Wroclaw

dermMedica Sp z.o.o, Wroclaw

Wromedica, Wroclaw

20-080

Maxxmed Centrum Zdrowia i Urody, Lubin

60-369

Centrum Medyczne Grunwald, Poznan

60-529

Solumed Centrum Medyczne, Poznan

01-142

Clinical Research Group Sp. z o.o., Warsaw

01-496

Royalderm Agnieszka Nawrocka, Warsaw

02-793

Clinical Best Solutions, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UNION therapeutics

INDUSTRY

NCT05469464 - Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) | Biotech Hunter | Biotech Hunter